Stocks
CONMED (CNMD) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 17.7% | 0.75% | 15.5% | 20.8% | 11.2% | 15.4% | ||
| Changes by years, y/y, % | +4pp | -17pp | +15pp | +5pp | -10pp | -3.9% | |||
CONMED. EBITDA margin, %
CONMED. EBITDA margin, changes, pp
CONMED (CNMD) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 7.64% | 14.8% | 7.37% | 14.9% | 12.1% | 15.4% | |
| Changes by years, y/y, % | -9pp | -5pp | -19pp | -6pp | +4pp | |||
| Changes by quarters, q/q, % | -13pp | +7pp | -7pp | +7pp | -3pp | |||
